Allaire G S, Rabin L, Ishak K G, Sesterhenn I A
Department of Hepatic Pathology, Armed Forces Institute of Pathology, Washington, D.C. 20306-6000.
Am J Surg Pathol. 1988 Sep;12(9):708-15. doi: 10.1097/00000478-198809000-00007.
In order to determine the morphologic spectrum of bile duct adenoma (BDA), we reviewed the clinical, gross, and histopathological features of 152 cases. All BDA were asymptomatic nodules discovered incidentally during intra-abdominal surgery (103 cases) or at autopsy (49 cases). They were usually subcapsular, ranged in size from 1 to 20 mm (mean, 5.8 mm), and were well circumscribed but nonencapsulated. Histologically, BDA was composed of benign, noncystic ductules and variable degrees of inflammation and fibrosis. The immunophenotype of these ductules was similar to that of interlobular bile ducts. Follow-up of 38 of the surgically treated patients confirmed the benign behavior of this lesion. BDA should be distinguished from an adenocarcinoma by the absence, in the former, of nuclear hyperchromasia, mitotic activity, and vascular invasion. The absence of bile and cystic changes and lack of association with polycystic disease of the liver and kidneys are the main features distinguishing BDA from von Meyenburg complex. We believe that BDA is a reactive process to a focal injury rather than a true neoplasm or a developmental anomaly.
为了确定胆管腺瘤(BDA)的形态学谱,我们回顾了152例患者的临床、大体及组织病理学特征。所有BDA均为在腹部手术(103例)或尸检(49例)时偶然发现的无症状结节。它们通常位于包膜下,大小从1至20毫米不等(平均5.8毫米),边界清楚但无包膜。组织学上,BDA由良性、非囊性小胆管以及不同程度的炎症和纤维化组成。这些小胆管的免疫表型与小叶间胆管相似。对38例接受手术治疗的患者进行随访,证实了该病变的良性行为。BDA应与腺癌相鉴别,前者不存在核深染、有丝分裂活性及血管侵犯。无胆汁及囊性改变以及与肝肾多囊病无关是BDA与梅耶尔堡复合体(von Meyenburg complex)相鉴别的主要特征。我们认为BDA是对局灶性损伤的一种反应性过程,而非真正的肿瘤或发育异常。